Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10373)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 15, 2021 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Krepel Volsky S, Shalitin S, Fridman E, Yackobovitch-Gavan M, Lazar L, Bello R, Oron T, Tenenbaum A, de Vries L, Lebenthal Y. Dyslipidemia and cardiovascular disease risk factors in patients with type 1 diabetes: A single-center experience. World J Diabetes 2021; 12(1): 56-68 [PMID: 33520108 DOI: 10.4239/wjd.v12.i1.56] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i1/56.htm |
| Number | Citing Articles |
| 1 |
Mariana Lourenço, Ana Rita Leite, Patrícia Ferreira, Inês Meira, João Menino, Ana Margarida Lopes, Joana Lagoa, Beatriz Viveiros, Maria João Barbosa, Sílvia Santos Monteiro, Joana Queirós, João Sérgio Neves, Celestino Neves. Association of thyroid function within the normal range with glycemic control and cardiovascular risk factors in type 1 diabetes. Expert Review of Endocrinology & Metabolism 2025; : 1 doi: 10.1080/17446651.2025.2532560
|
| 2 |
M. M. Shchurko, L. Ye. Lapovets, N. R. Demianchuk, V. M. Akimova. MODERN VIEWS ON THE PATHOGENESIS OF IMMUNE DYSFUNCTION AGAINST THE BACKGROUND OF THE METABOLIC SYNDROME IN ISCHEMIC HEART DISEASE. Ukrainian Journal of Laboratory Medicine 2023; 1(2): 60 doi: 10.62151/2786-9288.1.2.2023.08
|
| 3 |
Empar Lurbe. Blood Pressure Disorders in Diabetes Mellitus. Updates in Hypertension and Cardiovascular Protection 2023; : 21 doi: 10.1007/978-3-031-13009-0_2
|
| 4 |
Yuan Kong, Qi-Qi Xing, Yu-Xuan Tian, Lin Li, Pan Yu, Lin-Guo Zhao, Dong-Dong Li. Design, synthesis, and biological activity of 9-O-cinnamoylberberines as novel lipid-lowering agents. Natural Product Research 2023; 37(20): 3452 doi: 10.1080/14786419.2022.2085697
|
| 5 |
Avivit Brener, Sandy Hamama, Hagar Interator, Asaf Ben Simon, Irina Laurian, Anna Dorfman, Efrat Chorna, Michal Yackobovitch‐Gavan, Asaf Oren, Ori Eyal, Yael Lebenthal. Sex differences in body composition in youth with type 1 diabetes and its predictive value in cardiovascular disease risk assessment. Diabetes/Metabolism Research and Reviews 2023; 39(1) doi: 10.1002/dmrr.3584
|
| 6 |
Ana Margarida Lopes, Ana Rita Leite, Patrícia Ferreira, Inês Meira, João Menino, Mariana Lourenço, Joana Lagoa, Beatriz Viveiros, Maria João Barbosa, Sílvia Santos Monteiro, Joana Queirós, João Sérgio Neves, Celestino Neves. Prevalence of autoimmune comorbidities and association with glycemic control by CGM-derived parameters in type 1 diabetes. Endocrine 2025; doi: 10.1007/s12020-025-04354-0
|
| 7 |
Joonsang Yoo, Jimin Jeon, Minyoul Baek, Sun Ok Song, Jinkwon Kim. Impact of statin treatment on cardiovascular risk in patients with type 1 diabetes: a population-based cohort study. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04691-6
|
| 8 |
Tamar Propper-Lewinsohn, Shlomit Shalitin, Michal Gillon-Keren, Michal Yackobovitch-Gavan, Alon Liberman, Moshe Phillip, Roni Elran-Barak. Glycemic Variability and Disordered Eating Among Adolescents and Young Adults with Type 1 Diabetes: The Role of Disinhibited Eating. Diabetes Technology & Therapeutics 2025; 27(2): 113 doi: 10.1089/dia.2024.0267
|
| 9 |
Tamar Propper-Lewinsohn, Roni Elran-Barak, Michal Gillon-Keren, Michal Yackobovitch-Gavan, Alon Liberman, Moshe Phillip, Shlomit Shalitin. Disordered Eating Behaviors Among Adolescents and Young Adults with Type 1 Diabetes Treated with Insulin Pumps and Hybrid Closed-Loop Systems. Diabetes Technology & Therapeutics 2024; 26(4): 229 doi: 10.1089/dia.2023.0500
|